Merck reports surging sales of vaccines and key cancer drug - Washington Post

Merck reports surging sales of vaccines and key cancer drug  Washington Post

Merck breezed past almost all expectations for the first quarter with global sales jumping 8 percent to almost $11 billion.



Comments

Popular posts from this blog

Oncology: The disease, dynamics & challenges of market research

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Lung Cancer Among People Who Never Smoked